Candi5V study

A vaccine against candida in women with recurrent vulvovaginal candidiasis (RVVC)

A very frequent problem among women is recurrent vaginal yeast infections. Currently, only treatment with medication exists. But long-term use of medication has numerous disadvantages such as lack of response or overtime habituation. There is an urgent need for a vaccine.

We are proud to test a new vaccine against vaginal yeast infections as a first.